BRIEF-Obagi Medical Products up in premarket; to be acquired by Valeant Pharma

Wed Mar 20, 2013 8:34am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

NEW YORK, March 20 (Reuters) - Obagi Medical Products Inc : * Up 28.3 percent to $19.75 in premarket; to be acquired by Valeant Pharmaceuticals for $19.75 per share